Citadel Advisors - APREA THERAPEUTICS INC ownership

APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 42 filers reported holding APREA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of APREA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$107,925
-51.8%
335,276
-2.5%
0.00%
Q3 2022$224,000
-23.8%
343,900
-13.3%
0.00%
Q2 2022$294,000
-64.4%
396,781
-10.7%
0.00%
Q1 2022$826,000
-6.6%
444,282
+44.5%
0.00%
Q4 2021$884,000
-37.3%
307,561
+11.4%
0.00%
Q3 2021$1,411,000
+214.3%
276,149
+200.4%
0.00%
Q2 2021$449,000
+116.9%
91,919
+127.0%
0.00%
Q1 2021$207,000
-88.4%
40,500
-45.3%
0.00%
-100.0%
Q3 2020$1,783,000
-85.1%
74,073
-76.0%
0.00%
-75.0%
Q2 2020$11,981,000
+7.3%
308,948
-3.8%
0.00%
-20.0%
Q1 2020$11,166,000
-21.3%
321,241
+4.0%
0.01%
-16.7%
Q4 2019$14,181,000309,0120.01%
Other shareholders
APREA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Princeton Global Asset Management LLC 100$4440.00%
Quent Capital, LLC 3$130.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of APREA THERAPEUTICS INC shareholders